Daubert: Very Convoluted, Usually Confusing to Many, Nevertheless Elegant

Armand Rossetti
Armand Rossetti
Contributor
Posted by Armand RossettiAugust 06, 2009 4:32 PM

Pretrial Daubert hearings are essentially motions in limine that ultimately decide whether an expert is qualified, and whether that expert: 1) has based an opinion on sufficient facts or data; 2) will be able to testify using “reliable principles and methods,” and; 3) has applied the principles and methods reliable to the particular facts of a given case.

The Daubert factors are based Rule 702 of the Federal Rules of Evidence, which is used to examine an expert’s testimony as a whole. In addition under Rule 703, experts may reasonably rely on documents and information that may be inadmissible during trial. It is also Rule 703 that forms the basis for inquiry, concerning the reliability of any data that supports expert testimony. Furthermore, Rule 703 relaxes the requirement that experts need to acquire personal knowledge about the matter to which they testify. Finally, Rule 703 has little to do with whether an expert’s testimony, as a whole, meets Daubert standards. That determination rests with Rule 702.

Since a Rule 702 is more “holistic,” judges acting as gatekeepers should not require each document, or particular source of data that experts might use to form opinions, to be dispositive. In other words, Courts should not be conducting a Daubert inquiry on each and every document and deciding whether or not each document is qualified as being stand-alone reliable.

Instead, Judges should conduct a Rule 702 analysis in light of an expert’s reasoning and methodology in its entirety, or to analogize, judges should decide testimonial reliability under the totality of the medical, scientific and technical circumstances.

Daubert also requires that an expert witness has to assist and not to confuse the Trier of fact. If the Jury (Trier of fact) can understand whether a substance in particular is able to cause an injury and whether an injury resulted from that particular substance, an expert opinion would be redundant and unnecessary.

On the other hand, Rule 403 requires a Court to balance the probative value against the prejudicial effects of expert witness testimony. Courts should not confuse Rule 403 with Rule 703.

For example, experts do not necessarily need an epidemiological study with an internal control group or randomly selected participants to be able to show an association between exposure to a chemical and resulting bodily abnormalities. That is true because an association is not causation. While a case study might not be sufficient to show causation, it may be all that is necessary to show an association between presence of a toxic substance and a resulting injury.

However, if a Court mistakenly uses Rule 403 in place of Rule 703 to disqualify a source of information because that source in itself does not suffice in supporting causation, that Court has prematurely obviated the need to take all of the information, in the aggregate, and to perform a Rule 702 analysis to examine an experts methodology.

It is the expert in the first instance, and not the Court as gatekeeper, who is the judge of what recourses to choose to assist her in forming an opinion. It is the expert who will initially filter out prejudicial information as being irrelevant. The Court then uses Rule 703 to assure the reliability of evidence by vetting the bases that forms an expert’s testimony.

Let's take environmental asbestos infiltration an example, the fact that an air sampling study is an associational (or case) study affecting a few subjects, rather than a higher evidence based epidemiological study that affects several hundred subjects should not bar an expert from using the case study to inform her opinion about the dangers of asbestos release in the environment. The fact that a single case study published in a peer reviewed journal fails to establish causation under a Rule 703 review should go to the weight that the Jury will give such evidence, but it does not mean that an expert cannot eventually rely upon it in part to form an ultimate opinion.

Of course, if a single case study were the only source of evidence, then the Court might be reasonable in immediately performing a Rule 702 analysis to disqualify the entire testimony. However, the fact that an expert has relied upon several case studies to form an opinion, and has not used even one single epidemiological study should not in itself disqualify that expert’s testimony.

Rule 703 also addresses whether a study is of the type usually relied upon by experts in the field. Experts in different fields may rely upon different types of studies that span several different evidence based scientific levels. Certain professions might consider lower levels of scientific evidence as being adequate to enlighten the community about dangers inherennt in certain practices and procedures. In many instances, legal, ethical or moral considerations render higher evidence based, epidemiological studies forever unavailable.

For instance, the profession of orthopedic surgeons (community) may require only a certain number of evidence based medicine (EBM) level IV, peer reviewed case studies, instead of level I epidemiological studies, before that community decides to strongly recommend that surgeons discontinue using a certain procedure. In particular, the community may determine that a medical device, such as a pain pump that employs a medication, such as bupivacaine, is causing shoulder chondrolysis at a much higher than usual incidence. The community then conducts several different types of level IV EBM studies that expose the pump and anesthetic as being too dangerous for continued use in joints between bones. Just because it is unethical to conduct double blind, epidemiological studies, Courts should not consider the entire orthopedic decision making process to be less “scientific” than other such investigations.

If under Rule 703, Courts were to individually disqualify each and every level IV article as being insufficient and/or unreliable to base an association that might in light of additional studies, lead to causation, no orthopedic expert would be able to gather any evidence to form an opinion, and have a Court perform a Rule 702 analysis. That is the primary reason that many document-by-document decisions that have incorrectly occurred under Rule 703 have unfairly usurped the expert’s opportunity to undergo a required Rule 702 review under Daubert. This means that many plaintiffs and perhaps many defendants have not had their day in court. For a more comprehensive discussion, see US v. WR Grace.

2 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Lana KeetonInjuryBoard Contributor
Posted by Lana Keeton
August 13, 2009 1:28 AM

It may be convulted and elegant but don't get caught in the web of Daubert woven by major corporations pre-emptive strikes against Plaintiff's complaints.

Prosecuting Ethicon, Gynecare Worldwide and Johnson & Johnson in a product liability lawsuit for their defective Gynecare TVT System and its Prolene polypropylene Synthetic Surgical Mesh, I ran head on into Daubert....my extremely qualified expert witness, a textile engineer, who had worked for years for a device maker, and reverse engineered the actual product causing the harm, was excluded.

My head on collision with Daubert had started years before the actual Daubert v. Merrell Dow Pharmaceuticals Inc Supreme Court Decision on June 28, 1993.

Corporations who were losing millions and millions in toxic tort cases very smartly changed culture and the law by supporting Peter Huber and the ultra-Conservative Manhattan Institute .

Sixteen years later this is so embedded in the legal system, the best hope you have to keep your expert witness and survive summary judgment is to make sure you demonstrate in your motions and expert witness depositions is that the Supreme Court decision had no intention to make the Daubert criteria “a definitive checklist or test” .

Don't get mired in the details of Daubert. You will be caught in the spider web woven by major corporations to stop Plaintiff's attorneys from successfully prosecuting VERY IMPORTANT toxic mass torts.

Below are excertps from “Daubert: The Most Influential Supreme Court Ruling You’ve Never Heard Of". Please go to More ... " rel="nofollow">More ... to read the entire article.

“Daubert: The Most Influential Supreme Court Ruling You’ve Never Heard Of"

A Publication of the Project on Scientific Knowledge and Public Policy, coordinated by the Tellus Institute, 11 Arlington St., Boston MA 02116 More ... " rel="nofollow">More ... June 2003

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

TEN YEARS AGO, on June 28, 1993, the United States Supreme Court issued an opinion relating to how federal judges should decide whether to allow expert testimony into the courtroom. Prior to this, most federal and state court judges had been relying upon two standards to decide if expert testimony was admissible: relevance (if the testimony addressed a fact at issue in the case and if it would be helpful to the jury); and a 1923 ruling known as Frye, which held that the methods used by the expert in forming his scientific conclusions must be generally accepted within the expert community. Critics of Frye argued that it often excluded new but legitimate science that had not yet gained a consensus within the scientific community.

Moreover they pointed out that science was not a “majority rules” endeavor. On the other hand, others argued that abandoning the Frye standard and relying merely on the relevance standard allowed in too much science that was poorly designed or not reliable – what some chose to call “junk science.”

The Supreme Court sought to clarify these standards in Daubert v. Merrell Dow Pharmaceuticals, Inc.1 by directing judges to act as “gatekeepers” in the courtroom. It instructed judges to examine the scientific method underlying expert evidence and to admit only that evidence that was both “relevant and reliable.” Two later cases, General Electric v. Joiner and Kumho Tire Co. v. Carmichael, expanded upon this opinion. 2

In Joiner, the Supreme Court ruled that appellate courts should not overturn the admissibility decision of a trial court unless the trial court abused its discretion, an extremely difficult thing to show. Kumho clarified the Daubert ruling by finding that it should be applied to all expert testimony, including testimony based on experience, not merely that which relied upon science.

But what started as a well-intentioned attempt to ensure reliable and relevant evidentiary science has had troubling consequences. Over the past 10 years some judges, in our opinion, have routinely misinterpreted and broadened the reach of Daubert, which has become the latest and most effective tool used by tort defendants to protect themselves from product liability and personal injury cases. Polluters and manufacturers of dangerous products are successfully using Daubert to keep juries from hearing scientific or any other evidence against them.

In the aftermath of Daubert, not only are many legitimate scientists and their work being barred from the courtroom, but plaintiffs are being denied their day in court, unfairly in our view. Much of the evidence that forms the basis of a plaintiff ’s case, from the safety of drugs and consumer products to whether pollution has caused harm, is based on science. In many cases, pre-trial “Daubert hearings” exclude so much of the evidence upon which plaintiffs intend to rely that a given case cannot proceed.

Armand RossettiInjuryBoard Contributor
Posted by Armand Rossetti
August 13, 2009 8:39 AM

Reply to the Comment:

Posted by Lana Keeton
August 13, 2009 1:28 AM

Beginning with:

It may be convulted and elegant but don't get caught in the web of Daubert woven by major corporations pre-emptive strikes against Plaintiff's complaints.

I am so pleased that you took the time to compose and to post such a well reasoned and important comment.

While surfing for Daubert related information the other day, I happened upon an article, which contained the following statement:

"[] Rule 702 and Daubert leave open the possibility that a proponent of expert testimony can argue that the testimony is admissible as "technical" knowledge or "specialized" knowledge even when the testimony falls short of qualifying as "scientific" knowledge.

More ...

I thought about the content of that statement and I can add the following as an example and further comment:

Orthopedic surgeons are using medical knowledge ("specialized knowledge"; a combination of "medical" and "scientific" knowledge), which they gain by reviewing peer reviewed, EBM level IV case studies. A level IV review, coupled with decision making that is generally acceptable in the profession of orthopedic surgery should be sufficient enough, under the preponderance acceptability rule, to get the expert past the threshold of gate keeping and into the courtroom before the Jury.

A "specialized knowledge" argument (when viewed in light of the Rules 702, 703, and 403 judicial opinions in US v. WR Grace) should pass Daubert muster. An orthopedic surgeon who proffers expert testimony, regarding, let’s say, chondrolysis should be able to offer testimony to the Jury based on a group of level IV articles and laboratory studies that show a connection between intra-articular dose-time delivery of bupivacaine and PAGCL, and the Jury should then be able to decide what level of credibility to assign that testimony.

Therefore, an article by article analysis under Rule 702 of each case study and obviation of a group of in vitro animal and human tissue laboratory studies that actually show a dose-time close relationship between bupivacaine toxicity to chondrocytes after only 30 minutes of exposure is not the process or result that 702 intended. Certainly, any peer reviewed, EBM level IV based article is not "junk science," And a group of case reviews, coupled with appropriate laboratory studies that obviously point to dose-time related chondrotoxicity should be sufficient to permit a Jury to assign weight to such evidence at trial.

Medicine is both an art and a science, and the art component (i.e., reviewing an aggregate of lower level evidence in order to change standard practice) is “specialized knowledge” that orthopedic surgeons, as a community use all the time. To declare otherwise, is to reduce the entire orthopedic profession to a grouping of junk scientists who wantonly perform surgery, and who are a clear danger to the public; and we know in our hearts and minds that such is not the case.

Under the current Daubert debacle, to say that certain Jurists cannot see the forest for the trees, may be a gross understatement, and review under an abuse of discretion standard just continues to encourage disparate rulings.

Comments for this article are closed.

Subscribe to InjuryBoard West Palm Beach

InjuryBoard West Palm Beach RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board West Palm Beach is brought to you by Searcy Denney Scarola Barnhart & Shipley, PA

Legal Assistance Center

More Info
Searcy Denney Scarola Barnhart & Shipley, PA (866) 735-1102 Ext 700 www.searcylaw.com
google
Personal Injury Lawyers Serving: Nationwide practice, including West Palm Beach, Palm Beach, Belle Glade, Boca Raton, Boynton Beach, Clewiston, Delray Beach, Fort Pierce, Greenacres, Hobe Sound, Jupiter, Lake Worth, Okeechobee, Palm City, Port Saint Lucie, Riviera Beach, Stuart
2139 Palm Beach Lakes Blvd., West Palm Beach, Florida 33409 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address